000650 深市 仁和药业

仁和药业股份有限公司

    2020 年上半年

      （未经审计）

        财

        务

        报

        告

  二 O 二 O 年八月二十六日


                  仁和药业股份有限公司

                          资产负债表

编制单位：仁和药业股份有限公司            2020 年 6 月 30 日            单位：人民币元
法定代表人：              主管财务负责人：                会计机构负责人：


                  仁和药业股份有限公司

                      合并资产负债表

编制单位：仁和药业股份有限公司            2020 年 6 月 30 日            单位：人民币元
法定代表人：              主管财务负责人：                会计机构负责人：


                  仁和药业股份有限公司

                          利润表

编制单位：仁和药业股份有限公司          2020 年 1-6 月              单位：人民币元
法定代表人：              主管财务负责人：                会计机构负责人：


                  仁和药业股份有限公司

                        合并利润表

编制单位：仁和药业股份有限公司          2020 年 1-6 月          单位：人民币元
法定代表人：              主管财务负责人：                会计机构负责人：

                  仁和药业股份有限公司

                        现金流量表

编制单位：仁和药业股份有限公司          2020 年 1-6 月          单位：人民币元
法定代表人：              主管财务负责人：                会计机构负责人：

                  仁和药业股份有限公司

                      合并现金流量表

编制单位：仁和药业股份有限公司          2020 年 1-6 月          单位：人民币元
法定代表人：              主管财务负责人：                会计机构负责人：

                                  所有者权益变动表

编制单位：仁和药业股份有限公司                                    2020 年 6 月                                    单位：人民币元

              项目                                                              本年金额

                                  实收资本(或股本)      资本公积    减：库存股    盈余公积        未分配利润      所有者权益合计

  一、上年年末余额                          1,238,340,076.00        430,159,626.77            -        234,197,682.27        517,167,275.17        2,419,864,660.21

      加：会计政策变更

          前期差错更正

  二、本年年初余额                          1,238,340,076.00        430,159,626.77            -        234,197,682.27        517,167,275.17        2,419,864,660.21

  三、本年增减变动金额（减少以“-”号填列）                                                                                  -117,447,844.40          -117,447,844.40

 （一）综合收益总额                                                                                                    6,386,163.20            6,386,163.20

 （二）股东投入和减少资本
 1．股东投入的普通股
 2．其他权益工具持有者投入资本
 3．股份支付计入股东权益的金额
 4．其他

 （三）利润分配                                                                                                      -123,834,007.60          -123,834,007.60

 1．提取盈余公积                                                                                                                                      -

 2．对股东的分配                                                                                                    -123,834,007.60          -123,834,007.60

 3．其他
 （四）股东权益内部结转

    1．资本公积转增股本

    2．盈余公积转增股本

    3．盈余公积弥补亏损

    4．结转重新计量设定受益计划净
 负债或净资产所产生的变动

    5．其他
 （五）专项储备

    1．本期提取

    2．本期使用
 （六）其他

  四、本年年末余额                          1,238,340,076.00        430,159,626.77            -        234,197,682.27        399,719,430.77        2,302,416,815.81


                                  所有者权益变动表

编制单位：仁和药业股份有限公司                                    2020 年 6 月                                    单位：人民币元

              项目                                                              上年金额

                                  实收资本(或股本)      资本公积    减：库存股    盈余公积        未分配利润      所有者权益合计

  一、上年年末余额                          1,238,340,076.00        430,159,626.77                    234,197,682.27        682,585,114.18        2,585,282,499.22

      加：会计政策变更

          前期差错更正

  二、本年年初余额                          1,238,340,076.00        430,159,626.77                    234,197,682.27        682,585,114.18        2,585,282,499.22

  三、本年增减变动金额（减少以“-”号填列）                                                                                  -165,417,839.01          -165,417,839.01

 （一）综合收益总额                                                                                                    -33,664,847.44          -33,664,847.44

 （二）股东投入和减少资本                                                                                              -7,918,983.97            -7,918,983.97

 1．股东投入的普通股
 2．其他权益工具持有者投入资本
 3．股份支付计入股东权益的金额

 4．其他                                                                                                                -7,918,983.97            -7,918,983.97

 （三）利润分配                                                                                                      -123,834,007.60          -123,834,007.60

 1．提取盈余公积                                                                                                                -                      -

 2．对股东的分配                                                                                                      -123,834,007.60          -123,834,007.60

 3．其他
 （四）股东权益内部结转

    1．资本公积转增股本

    2．盈余公积转增股本

    3．盈余公积弥补亏损

    4．结转重新计量设定受益计划净
 负债或净资产所产生的变动

    5．其他
 （五）专项储备

    1．本期提取

    2．本期使用
 （六）其他

  四、本年年末余额                          1,238,340,076.00        430,159,626.77            -        234,197,682.27        51